Derechos | Equipo Nizkor
Sputnik V effective against omicron variant - RDIF
Russia’s Sputnik V anti-coronavirus vaccine has proven a good level of efficacy against the omicron variant of the novel coronavirus, Russian Direct Investment Fund (RDIF) head Kirill Dmitriev was quoted as saying in the vaccine’s Twitter account on Saturday.
"You need to make sure vaccine works against current and future mutations. In that regard Sputnik platform is doing very well, showing good virus neutralization against Omicron," Dmitriev said in a BBC interview.
In his words, booster vaccines, such as Sputnik Light, as well as combinations of existing vaccines are extremely important in the fight against emerging variants of the novel coronavirus.
On November 26, the World Health Organization (WHO) designated the B.1.1.529 variant identified in South Africa as a "Variant of Concern" and assigned it the Greek letter omicron. In its statement, the WHO noted that "this variant has a large number of mutations, some of which are concerning." To date, as many as 783 Omicron cases have been identified in Russia.
[Source: Tass, Moscow, 16Jan22]
|This document has been published on 28Jan22 by the Equipo Nizkor and Derechos Human Rights. In accordance with Title 17 U.S.C. Section 107, this material is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes.|